Results 181 to 190 of about 471,997 (328)

Weizmannia coagulans XY2 Mitigates Copper Neurotoxicity via Gut–Brain Axis Modulation of Tryptophan Metabolism and Oxidative‐Inflammatory Crosstalk

iMetaOmics, EarlyView.
Copper interferes with tryptophan metabolism and 5‐HT levels by modulating intestinal flora. Intestinal barrier breakdown and inflammatory response trigger nerve damage under copper exposure. W. coagulans XY2 alleviates copper‐induced neurotoxicity by targeting a multi‐dimensional “tryptophan metabolism‐antioxidant defense‐gut‐brain axis” network.
Yufang Gao, Xiaodong Zheng, Fujie Yan
wiley   +1 more source

Second-line treatment strategies of ulcerative colitis after conventional therapy failure: A systematic review and network meta-analysis of randomized controlled trials. [PDF]

PLoS One
Xu Y, Jiang W, Jiang M, Zhu B, Huo J, Wu M, Yang L.   +6 more
europepmc   +1 more source

The Arthritis of Ulcerative Colitis [PDF]

BMJ, 1959
V, WRIGHT, G, WATKINSON
openaire   +3 more sources

iMeta Conference 2025: Creating high‐impact international journals

iMeta, EarlyView.
The iMeta Conference 2025, part of the iMeta Conference series, themed “Creating High‐Impact International Journals,” held at the Huangjiahu Campus of Hubei University of Chinese Medicine from August 23rd to 25th, 2025, and focused on frontier topics such as microbiology, medicine, traditional Chinese medicine, botany, and research career development ...
Zhihao Zhu, Lin Zhang, Xiaofang Yao, Meiyin Zeng, Yao Wang, Hao Luo, Yuanping Zhou, Tianyuan Zhang, Jiani Xun, Defeng Bai, Haifei Yang, Shanshan Xu, Yang Zhou, Yunyun Gao, Jinbo Xu, Wei Han, ZiAng Shen, Bangzhou Zhang, Tengfei Ma, Xiu‐Lin Wan, Chuang Ma, Fengjiao Hui, Hao Bai, Lijing Bai, Qing Bai, Qiangguo Bao, Guodong Cao, Peng Cao, Qiqi Cao, Hu Chen, Jiawen Chen, Jiaxu Chen, Lihua Chen, Tingting Chen, Yi Chen, Haipeng Cui, Shaoxing Dai, Xi‐Jian Dai, Xiaofeng Dai, Yanqi Dang, Lei Deng, Yun Deng, Xia Ding, Binhua Dong, Ling Dong, Shujie Dou, Hongzhi Du, Zhencheng Fang, Xiaoxiao Feng, Min Fu, Yuan Gao, Wenping Gong, Xiang Guo, Wenjie Han, Zikai Hao, Zheng‐Guo He, Haibo Hu, Haiming Hu, Xuefei Hu, Liang Huang, Xianya Huang, Xueting Huang, Haochen Hui, Dingjiacheng Jia, Aimin Jiang, Di Jiang, Kun Jiang, Dewei Jiang, Ying Jin, Kunyang Lai, Chun Li, Feng Li, Fuyong Li, Jing Li, Juan Li, Junling Li, Kui Li, Ling Li, Moli Li, Peiwu Li, Peng Li, Runze Li, Shengnan Li, Shujin Li, Wanting Li, Wenting Li, Xiaojing Li, Xinrui Li, Xuemeng Li, Qiqi Liang, Xiaoping Liao, Boyang Liu, Canzhao Liu, Chang Liu, Duanrui Liu, Furong Liu, Jianjun Liu, Jinyao Liu, Siqi Liu, Tianyang Liu, Wenjuan Liu, Yan Liu, Yang Liu, Yi Liu, Yuan Liu, Yunhuan Liu, Zhipeng Liu, Zhiyong Liu, Xin Lu, Xiao Luo, Guanju Ma, Jialin Meng, Yuanfa Meng, Runyu Miao, Linxuan Miao, Yawen Ni, Dongze Niu, Tingting Niu, Hongzhao Pan, Guoqiang Qin, Tiantian Qiu, Yueping Qiu, Hui Qu, Linghang Qu, Na Ren, Qiang Sun, Run Shang, Peize She, Xihui Shen, Bohan Shi, You Shu, Jiawei Song, Weibin Song, Qi Su, Qingzhu Sun, YuPing Sun, Zijin Sun, Bufu Tang, Deqin Tang, Hua Tang, Yongfu Tao, Teng Teng, Yanye Tu, Cheng Wang, Hui Wang, Yunhao Wang, Chunli Wang, Dingjie Wang, Gang Wang, Jin Wang, Kaiyi Wang, Mingbang Wang, Shan Wang, Shixiang Wang, Xiaojie Wang, Xing‐Chang Wang, Yunzhe Wang, Jiale Wang, Zheng Wang, Weijie Wang, Yongjun Wei, Wei Xu, Fan Wu, Junling Wu, Shijuan Wu, Jian Xiao, Weihua Xiao, Yang Xiao, Xi Xiong, Xue Xiong, Feng Xu, Junyu Xu, Wen Xu, Jun Xu, Yao Xu, Jun Yan, Lutian Yao, Jia Yang, Lulu Yang, Xingzhen Yang, Naiyi Yin, Hua You, Min You, Ting Yu, Yongyao Yu, Renqiang Yu, Shuofeng Yuan, Chaoxiong Yue, Xiaoya Zeng, Andong Zha, Leilei Zhai, Chi Zhang, Dong Zhang, Hengguo Zhang, Heng Zhang, Hongyu Zhang, Jiahao Zhang, Jinyang Zhang, Lishan Zhang, Qi Zhang, Xiang Zhang, Xiangyu Zhang, Xuelei Zhang, Yancong Zhang, Yuan Zhang, Zhenyu Zhang, Jiwei Zhao, Jingxuan Zhao, Kai Zhao, Mingjuan Zhao, Yi Zhao, Yunxiang Zhao, Jixin Zhong, Ling Zhong, Xiangjian Zhong, Dan Zhou, Wei Zhou, Wen Zhou, Yiqian Zhou, Zhemin Zhou, Shiquan Zhu, Shuang‐Jiang Liu, Suyin Feng, Shuangxia Jin, Chuanxing Xiao, Ziheng Wang, Peng Luo, Tong Chen, Gang Chen, Yong‐Xin Liu   +229 more
wiley   +1 more source

Whole microbiota transplantation restores gut homeostasis throughout the gastrointestinal tract

iMeta, EarlyView.
This study introduces whole microbiota transplantation (WMT), a synergistic therapeutic approach that concurrently transplants small intestinal and fecal microbiota. In germ‐free mice, WMT outperforms conventional fecal microbiota transplantation (FMT) in restoring gut microbiota diversity and abundance.
Bufu Tang, Yuan Cao, Jiasu Li, Nan Gao, Pingting Gao, Xiaochao Chen, Zunzhen Ming, Zhaoshen Li, Weiliang Hou   +8 more
wiley   +1 more source

Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel disease. [PDF]

Oncologist
Barberio B, Patuzzi I, Bertin L, Facchin S, De Ruvo M, Bonazzi E, De Barba C, Dal Maso A, Frega S, Simionati B, Sattin E, Buda A, Zingone F, Burra P, Dei Tos AP, Pasello G, Bonanno L, Savarino EV.   +17 more
europepmc   +1 more source

Ulcerative Colitis [PDF]

Postgraduate Medical Journal, 1953
openaire   +2 more sources

The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease

Journal of Clinical Laboratory Analysis, EarlyView.
Bacterial and viral pathogens may play a key role in Behçet's disease (BD) pathogenesis by triggering autoimmunity, molecular mimicry, or microbiome disruption. These infectious agents could initiate inflammatory pathways, contributing to BD's diverse clinical manifestations.
Mohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, Marzieh Rezaei, Elahe Taki   +4 more
wiley   +1 more source

Homogalacturonan From Yellow Passion Fruit Peel Ameliorates Intestinal Injury in DSS-Induced Colitis in Mice. [PDF]

J Cell Mol Med
Mazeti SSS, Turini AA, Bueno LR, Lima CD, Bastos RS, Rocha JA, Cordeiro LMC, Maria-Ferreira D, Gois MB.   +8 more
europepmc   +1 more source

Clinical and Biochemical Factors Associated With Infliximab Pharmacokinetics in Adult Patients With Inflammatory Bowel Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool, Ilse Volkerink, Mirthe Stavast, Jos G. W. Kosterink, Gerard Dijkstra, Paola Mian, Arno R. Bourgonje   +6 more
wiley   +1 more source